Table 5.
Effect of DFMO on proliferative index of SCCs. Tumor-bearing K6/ODC transgenic mice of founder line 39/1m were administered 1% DFMO in their drinking water and sacrificed at the indicated times after the start of treatment. Control animals (n = 4) received regular drinking water and were sacrificed at various times throughout the 8 day experimental period. One hour before sacrifice, mice were injected i.p. with BrdUrd (100 μg/g body weight), and tumors and surrounding skin were processed for immunocytochemistry as described in Methods. Results represent counts of > 800 cells/section with 3–5 tumors per group.
| Group | No. of Cells Counted | % of Nuclei, BrdUrd-Positive (mean ± SE) | P Value* |
| Control | 4375 | 28.7 ± 3.6 | |
| DFMO, 1d | 4696 | 21.2 ± 3.9 | 0.13 |
| DFMO, 2d | 4339 | 7.8 ± 1.0 | 0.007 |
| DFMO, 4d | 6202 | 13.3 ± 1.9 | 0.004 |
| DFMO, 8d | 2651 | 14.4 ± 1.9 | 0.009 |
*vs control value (ANOVA)